Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • CluePoints Wins Growth Award at BVA Private Equity Awards

    Oct 24, 2024, 08:08 AM by
    CluePoints, provider of leading statistical and AI-driven software solutions, has been recognized for its impressive growth at the BVA Private Equity Awards.
    Full story
  • Cleveland Clinic Researchers Find Hope in Immune Cells’ Reaction to Immunotherapy

    Oct 23, 2024, 13:43 PM by User Not Found
    Bio-IT World | There is much we still don’t know about the relationship between immune cells and cancer cells and how they interact and influence each other over the course of immune activating cancer therapies. Researchers at Cleveland Clinic are exploring these relationships and reported their results last month in Nature Medicine.
    Full story
  • Biopharma PEG Provides Advanced PEG Solutions for Drug Development

    Oct 23, 2024, 08:15 AM by
    Biopharma PEG has launched a range of polyethylene glycol (PEG) products for PEGylation, improving drug efficacy. With over 40 approved PEGylated drugs, interest in monodispersed PEGs is growing, as seen with Movantik. Biopharma PEG is dedicated to supporting PEGylated drug development.
    Full story
  • DNAnexus Strengthens Leadership Team to Drive Ongoing Product Innovation and Commercial Growth

    Oct 23, 2024, 08:15 AM by
    DNAnexus announced the appointment of Nupura Kolwalkar as chief product officer and Bill Madigan as chief commercial officer.
    Full story
  • KLAS Research Recognizes Proscia For Improving Patient Outcomes

    Oct 23, 2024, 08:14 AM by
    Proscia was named to KLAS Research’s 2024 Emerging Solutions Top 20 list of technologies best positioned to impact the Quadruple Aim of Healthcare. Its Concentriq software platform was selected by healthcare leaders across the United States for improving patient outcomes. Awardees were celebrated at the HLTH USA event in Las Vegas, Nevada.
    Full story
  • Ellison Institute of Technology Los Angeles Accelerates Cancer Research with Sapio LIMS

    Oct 23, 2024, 08:14 AM by
    Sapio Sciences, the science-aware™ lab informatics platform, today announced that the Ellison Institute of Technology Los Angeles (EIT Los Angeles), a leading interdisciplinary research center focused on cancer and global health, has successfully deployed Sapio Sciences' Laboratory Information Management System (LIMS) to streamline its complex research operations and accelerate scientific discovery.
    Full story
  • Optibrium Demonstrates Superior Molecular Docking Method for Small Molecules and Macrocycles

    Oct 23, 2024, 08:14 AM by
    Optibrium, a leading developer of software and AI solutions for molecular design today announced the publication of a peer-reviewed study in the Journal of Computer-Aided Molecular Design, ‘Structure-Based Pose Prediction: Non-cognate Docking Extended to Macrocylic Ligands’. The paper demonstrates that Surflex-Dock can accurately predict the binding conformation and orientation (pose) of unknown (non-cognate) ligands, including macrocycles.
    Full story
  • Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

    Oct 22, 2024, 08:27 AM by
    Seer’s Proteograph™ Product Suite reveals new insights into Alzheimer’s pathways, drives population-scale plasma analysis, and captures immune dynamics in xenotransplantation—with additional breakthrough research from collaborators advancing proteomic discovery at scale
    Full story
  • Inizio Medical Appoints Patrick Giordani as SVP, AI Solutions Architect, Underpinning Commitment to Expanding AI Capabilities and Accelerating Innovation

    Oct 22, 2024, 08:27 AM by
    Full story
  • Phenomix Sciences and InformedDNA Partner to Advance Genetics-Driven Obesity Care

    Oct 18, 2024, 09:10 AM by
    Launching at HLTH 2024, the groundbreaking partnership offers payers, health systems, employers, and life science organizations access to personalized obesity care and treatment planning based on a patient’s DNA.
    Full story
  • DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform

    Oct 18, 2024, 09:10 AM by
    DNA Script announces Marc Montserrat's appointment as CEO.
    Full story
  • Firstsource positioned a ‘Leader’ in Everest Group's Healthcare Payer Business Process as a Service Solutions PEAK Matrix® Assessment 2024

    Oct 18, 2024, 09:10 AM by
    Full story
  • Healthcasts Names Max Baumer Chief Operating Officer & Chief Financial Officer

    Oct 17, 2024, 08:31 AM by
    Healthcasts, the leading online community for healthcare professional consultation and real-world experience, today announced the appointment of Max Baumer, CPA, as Chief Operating Officer and Chief Financial Officer. Baumer has spent over a decade overseeing finance and operations for companies experiencing exceptional growth including large hospital systems and healthcare staffing companies, making him uniquely positioned to bridge financial and operational duties in his role at Healthcasts.
    Full story
  • 90% of Hospital and Health System Revenue Cycle Leaders Believe GenAI Will Impact Medical Coding Operations

    Oct 17, 2024, 08:31 AM by
    Full story
  • Illumina’s New Desktop Sequencing Series Is Fast, Cheap, Simple

    Oct 17, 2024, 01:00 AM by User Not Found
    Bio-IT World | Illumina unveiled its MiSeq i100 Series of sequencing systems last week during an online customer event, comprising two new benchtop instruments: MiSeq i100 and MiSeq i100 Plus Systems. The MiSeq i100 will be available to ship globally in 2025.
    Full story
  • Pistoia Alliance Research Finds Concerns on Security, Barriers, More

    Oct 16, 2024, 15:18 PM by User Not Found
    Bio-IT World | As artificial intelligence (AI) and machine learning (ML) become increasingly prevalent in the industry, there are still several concerns about its implementation. Mainly, how safe is it to use AI? What measures can be taken to increase and reinforce security? The Pistoia Alliance decided to find out.
    Full story
  • CAI Unveils Bold New Brand Identity at ISPE Annual Meeting & Expo

    Oct 16, 2024, 08:22 AM by
    Full story
  • 1upHealth Launches 1up Patient Connect Product Update to Enhance Patient Data Interoperability Across the Industry

    Oct 16, 2024, 08:22 AM by
    Full story
  • Oxford University Hospitals NHS Foundation Trust Propels Digitisation with PhenoTips’ Genomic Health Record.

    Oct 15, 2024, 16:06 PM by
    Oxford University Hospitals NHS Foundation Trust (OUH) accelerates their Digital by Default strategy by harnessing PhenoTips’ cloud-hosted Genomic Health Record to digitise, integrate, and standardise genomic care.
    Full story
  • ‘Heretical’ Idea for Treating Triple-Negative Breast Cancer Moves Forward

    Oct 15, 2024, 15:03 PM by User Not Found
    Bio-IT World | The clinical utility of treating cancer by modulating the estrogen receptor could radically and quickly expand, initially for patients with triple-negative breast cancer but potentially thereafter to those with melanoma and cancers found in the colon, lung, head, and neck. Hope springs from findings emerging from the lab of Professor Donald McDonnell, Ph.D., at Duke University School of Medicine, where the field of oral selective estrogen down-regulators was pioneered nearly two decades ago.
    Full story
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16 (current)
  • 17
  • 18
  • 19
  • 20
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy